LOPID

LOE Approaching

gemfibrozil

NDAORALTABLET
Approved
Dec 1981
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
20

Mechanism of Action

Peroxisome Proliferator-activated Receptor alpha Agonists

Pharmacologic Class:

Peroxisome Proliferator Receptor alpha Agonist

Clinical Trials (5)

NCT05959447Phase 1Completed

Evaluation of the Potential Drug-drug Interactions Between Gemfibrozil or Dabigatran Etexilate and Camlipixant

Started Jul 2023
45 enrolled
CoughHealthy
NCT05932303Phase 1Completed

A Study to Assess the Effect of Multiple Doses of Itraconazole, Gemfibrozil, or Carbamazepine on BMS-986278 in Healthy Participants

Started Jul 2023
47 enrolled
Healthy Participants
NCT05335005Phase 1Completed

MK-2060 and Clopidogrel Co-administration Safety and Tolerability Study in Participants With End-Stage Renal Disease (ESRD) (MK-2060-008)

Started May 2022
12 enrolled
End-Stage Renal DiseaseKidney Failure, Chronic
NCT04956627Phase 1Completed

A Study to Assess the Effect of Itraconazole, Phenytoin and Gemfibrozil on the Drug Levels of BMS-986166 in Healthy Participants

Started Jul 2021
15 enrolled
Healthy Participants
NCT04688723Phase 4Unknown

Dual Therapy With Dabigatran/Ticagrelor Versus Dual Therapy With Dabigatran/Clopidogrel in ACS Patients With Indication for NOAC Undergoing PCI

Started Dec 2020
1,000 enrolled
Coronary Artery DiseaseMyocardial IschemiaMyocardial Infarction+1 more